The H.U. Group aims to become a comprehensive healthcare company with medical care at its core. To that end, we are strengthening healthcare based on the medical services of our Group companies, from our core businesses of lab testing and sterilization to diagnosis, treatment, prevention, care, and the establishment of social infrastructure in regional communities that combines ICT and testing.H.U. Frontier, which was established in 2020, consolidates the sales functions of the H.U. Group and optimizes each company’s highly socially beneficial business for each customer. H.U. Frontier will combine the strengths of the Group's wide range of products and services to offer comprehensive solutions to customers.H.U. Frontier will provide new business value from the integration of H.U. Group’s three businesses: Lab Testing and its related Services, In Vitro Diagnostics, and Healthcare-related Services. For example, in response to COVID-19, we offer a lineup of quantitative antigen tests, qualitative antigen tests, and PCR tests to meet a wide range of testing needs. In particular, our quantitative antigen testing has contributed greatly to Japan’s border control measures at airports. In addition, H.U. Frontier’s consultants propose various solutions based on customer needs, such as the adoption of a comprehensive contract scheme for medical institutions that includes off-site contract testing, in-house testing, and sterilization.08Solving customer issueswith comprehensive solutionsthat integrate sales functionsThe H.U. Group’s unique consulting proposalsALES HEADQUARTERSOLUTIONS
元のページ ../index.html#8